FDA approval of ANI PHARMS' ANDA075327 authorizes the commercial launch of the generic version of the prescription substance, positioning the company to capture immediate market share and generate revenue against the original brand competitor.
FDA approval of ANI PHARMS' ANDA075327 authorizes the commercial launch of the generic version of the prescription substance, positioning the company to capture immediate market share and generate revenue against the original brand competitor.